Article
QT and QTc interval with standard and supratherapeutic doses of darifenacin, a muscarinic M3 selective receptor antagonist for the treatment of overactive bladder.
Journal of clinical pharmacology - 1 Sept 2005
Serra Denise B, Affrime Melton B, Bedigian Martin P, Greig Gerard, Milosavljev Slavica, Skerjanec Andrej, Wang Yibin
Abstract excerpt
Prolongation of QT interval on an electrocardiogram is a valuable predictor of a drug's ability to cause potentially fatal ventricular tachyarrhythmia (torsades de pointes). Darifenacin is a muscarinic M3 selective receptor antagonist developed for the treatment of overactive bladder, a debilitating condition that is particularly prevalent in the older population. This 7-day, randomized, parallel-group study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
